# reload+after+2024-01-22 19:40:23.584494
address1§The Core
address2§Bath Lane Newcastle Helix
city§Newcastle upon Tyne
zip§NE4 5TF
country§United Kingdom
phone§44 19 1495 7325
website§https://www.skinbiotherapeutics.com
industry§Biotechnology
sector§Healthcare
longBusinessSummary§SkinBioTherapeutics plc, a life science company, engages in identification and development of technology that harnesses the human microbiome to improve health in the United Kingdom, the United States, and Europe. It develops SkinBiotix technology that promotes skin health by harnessing the beneficial properties of probiotic bacteria and the active components; and AxisBiotix technology that focuses on the gut-skin relationship and is designed to alleviate the symptoms associated with psoriasis. The company has an agreement with Croda Plc; and operates two research programmes with the University of Manchester, an oral programme and an inflammation study. It serves cosmetic skincare, food supplements, medical skin care, infection control, and pharmaceutical skincare markets. The company was formerly known as Skinbiotix Ltd and changed its name to SkinBioTherapeutics plc in December 2016. SkinBioTherapeutics plc was incorporated in 2015 and is based in Newcastle upon Tyne, the United Kingdom.
fullTimeEmployees§11
companyOfficers§[{'maxAge': 1, 'name': 'Mr. Stuart John Ashman', 'age': 56, 'title': 'CEO & Executive Director', 'yearBorn': 1967, 'fiscalYear': 2023, 'totalPay': 371103, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Manprit Singh Randhawa', 'age': 39, 'title': 'CFO, Secretary & Director', 'yearBorn': 1984, 'fiscalYear': 2023, 'totalPay': 261480, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': "Dr. Catherine  O'Neill", 'title': 'Chief Scientific Officer & Member of Scientific Advisory Board', 'fiscalYear': 2023, 'totalPay': 41795, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Laura  Bey', 'title': 'Head of Formulations', 'fiscalYear': 2023, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Melissa  Greenwell', 'title': 'Group Financial Controller', 'fiscalYear': 2023, 'exercisedValue': 0, 'unexercisedValue': 0}]
compensationAsOfEpochDate§1703980800
maxAge§86400
priceHint§2
payoutRatio§0.0
beta§1.636
priceToSalesTrailing12Months§241.45485
currency§GBp
exchange§LSE
quoteType§EQUITY
shortName§SKINBIOTHERAPEUTICS PLC ORD 1P
longName§SkinBioTherapeutics plc
firstTradeDateEpochUtc§1491375600
timeZoneFullName§Europe/London
timeZoneShortName§GMT
uuid§2ace95ad-1eda-3d52-bc4c-1d0021b987b0
targetHighPrice§53.0
targetLowPrice§53.0
targetMeanPrice§53.0
targetMedianPrice§53.0
recommendationMean§1.0
recommendationKey§strong_buy
numberOfAnalystOpinions§1
quickRatio§3.052
grossMargins§0.6451
ebitdaMargins§0.0
trailingPegRatio§None
